S. Akbaş Et Al. , "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373)," 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , Antalya, Turkey, 2022
Akbaş, S. Et Al. 2022. Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373). 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , (Antalya, Turkey).
Akbaş, S., Hırfanoğlu, T., Börcek, A. Ö., Atalay, T., Endürlük, S., Karaca, N. B., ... Cankurt, I.(2022). Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373) . 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , Antalya, Turkey
Akbaş, Salih Et Al. "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373)," 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , Antalya, Turkey, 2022
Akbaş, Salih Et Al. "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373)." 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , Antalya, Turkey, 2022
Akbaş, S. Et Al. (2022) . "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373)." 17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey , Antalya, Turkey.
@conferencepaper{conferencepaper, author={Salih Akbaş Et Al. }, title={Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 (EPO-373)}, congress name={17th International Child Neurology Congress, 3 - 07 October 2022, Antalya, Turkey }, city={Antalya}, country={Turkey}, year={2022}}